Literature DB >> 12402293

Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability.

Steven Vernino1, Vanda A Lennon.   

Abstract

Neuromuscular hyperexcitability is a characteristic of Isaacs' syndrome. Autoantibodies specific for voltage-gated potassium channels (VGKC) or ganglionic nicotinic acetylcholine receptors (AChR) are markers of this disorder. To determine the frequency of these ion channel antibodies and of related neuron- and muscle-specific antibodies in patients with acquired neuromuscular hyperexcitability, we tested serum specimens from 77 affected patients (35 neuromyotonia, 32 cramp-fasciculation syndrome, 5 rippling muscle syndrome, and 5 focal neuromuscular hyperexcitability) and 85 control subjects. Among study patients, 14% had coexisting myasthenia gravis, and 16% had an associated neoplasm. We found that 35% had VGKC antibodies, 12% ganglionic AChR antibodies, 16% muscle AChR antibodies, and 10% striational antibodies. Overall, 55% had serological evidence of neurological autoimmunity compared to 2% of control subjects. Patients with neuromyotonia were more frequently seropositive (71%) than patients with cramp-fasciculation syndrome (31%). We conclude that acquired neuromuscular hyperexcitability consists of a continuum of clinical disorders with a common autoimmune pathogenesis. Copyright 2002 Wiley Periodicals, Inc. Muscle Nerve 26: 702-707, 2002

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12402293     DOI: 10.1002/mus.10266

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  18 in total

Review 1.  Positive muscle phenomena--diagnosis, pathogenesis and associated disorders.

Authors:  Hans G Kortman; Jan H Veldink; Gea Drost
Journal:  Nat Rev Neurol       Date:  2012-01-24       Impact factor: 42.937

2.  P/Q- and N-type calcium-channel antibodies: Oncological, neurological, and serological accompaniments.

Authors:  Nicholas L Zalewski; Vanda A Lennon; Daniel H Lachance; Christopher J Klein; Sean J Pittock; Andrew Mckeon
Journal:  Muscle Nerve       Date:  2016-02-08       Impact factor: 3.217

3.  Acquired rippling muscle disease associated with mild myasthenia gravis: a case report.

Authors:  Sander M van Schaik; V I H Kwa; A J van der Kooi
Journal:  J Neurol       Date:  2009-03-07       Impact factor: 4.849

4.  Characterization of ganglionic acetylcholine receptor autoantibodies.

Authors:  Steven Vernino; Jon Lindstrom; Steve Hopkins; Zhengbei Wang; Phillip A Low
Journal:  J Neuroimmunol       Date:  2008-05-15       Impact factor: 3.478

Review 5.  The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases.

Authors:  Alina Sesarman; Gestur Vidarsson; Cassian Sitaru
Journal:  Cell Mol Life Sci       Date:  2010-03-09       Impact factor: 9.261

6.  A viral origin for benign fasciculation syndrome?

Authors:  Espen Skarstein Kolberg
Journal:  Neurol Sci       Date:  2020-11-09       Impact factor: 3.307

7.  Clinical utility of seropositive voltage-gated potassium channel-complex antibody.

Authors:  Adham Jammoul; Luay Shayya; Karin Mente; Jianbo Li; Alexander Rae-Grant; Yuebing Li
Journal:  Neurol Clin Pract       Date:  2016-10

8.  Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease.

Authors:  Michael D Geschwind; K Meng Tan; Vanda A Lennon; Ramon F Barajas; Aissa Haman; Christopher J Klein; S Andrew Josephson; Sean J Pittock
Journal:  Arch Neurol       Date:  2008-10

Review 9.  Neurologic paraneoplastic syndromes.

Authors:  Edward J Dropcho
Journal:  Curr Oncol Rep       Date:  2004-01       Impact factor: 5.075

Review 10.  Autoimmune and paraneoplastic channelopathies.

Authors:  Steven Vernino
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.